PHARMACIA ITALIA S.P.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
 
 
C07K PEPTIDES 2134
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the sameJun 15, 01Aug 21, 07[A61K]
7030089 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathioneApr 19, 01Apr 18, 06[A61K]
6576612 Antitumor therapy comprising distamycin derivativesOct 02, 00Jun 10, 03[A61K, C07D]
6482920 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agentsJan 22, 99Nov 19, 02[C07K]
6218148 DNS encoding stem cell factorDec 21, 93Apr 17, 01[C12N]
5798097 Immunogobulin conjugatesApr 11, 95Aug 25, 98[A61K, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivativesExpiredJun 20, 01Feb 04, 14[A61K, A01N, A61P]
2011/0166,077 COMBINED THERAPY AGAINST TUMORS COMPRISING SUBSTITUTED ACRYLOYL DISTAMYCIN DERIVATIVES AND RADIOTHERAPYAbandonedOct 01, 04Jul 07, 11[A61K]
7642229 Pharmaceutical composition and a product which includes a substituted acryloyl distamycin derivative, an antimicrotubule agent and/or an antimetaboliteExpiredJun 20, 01Jan 05, 10[A61K, C07K]
7399748 Antitumor therapy comprising distamycin derivativesExpiredSep 21, 01Jul 15, 08[A61K]
2007/0142,414 N-substituted pyrrolopyridinones active as kinase inhibitorsAbandonedDec 16, 05Jun 21, 07[A61K, C07D]
7201913 Oral formulations for anti-tumor compoundsExpiredOct 02, 00Apr 10, 07[A61K]
2006/0183,168 Method for optimizing therapeutic efficacy of nemorubicinAbandonedOct 08, 03Aug 17, 06[A61K, G01N]
2006/0084,612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitorsAbandonedDec 18, 02Apr 20, 06[A61K]
2006/0074,243 Hydroxamic acid and amide compounds and their use as protease inhibitorsAbandonedNov 10, 05Apr 06, 06[C07D]
2006/0046,993 Crystalline polymorphic form of irinotecan hydrochlorideAbandonedSep 01, 04Mar 02, 06[A61K, C07D]
7005285 Human p21-activated kinase 5 polypeptideExpiredNov 14, 00Feb 28, 06[C12N]
6974828 Propanoic acid derivatives as intergrin receptor antagonistsExpiredApr 19, 01Dec 13, 05[A61K, C07D]
6969592 Method for predicting the sensitivity to chemotherapyExpiredSep 26, 01Nov 29, 05[C12Q]
6951951 Process for preparing distamycin derivativesExpiredJun 14, 01Oct 04, 05[C07D]
2005/0176,796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agentsAbandonedApr 18, 05Aug 11, 05[A61K]
2005/0143,927 Method for estimating or predicting the anti-tumor activity of a compound and for estimating or predicting the tumor growth in mammalsAbandonedSep 15, 04Jun 30, 05[G06F]
6906199 Process for preparing distamycin derivativesExpiredNov 07, 01Jun 14, 05[A61K]
2005/0107,543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugatesAbandonedDec 01, 04May 19, 05[C07F, C08G]
2005/0059,156 Method for detecting contaminants in pharmaceutical productsAbandonedAug 05, 04Mar 17, 05[G01N, B01D]
2005/0038,112 Simplified sarcondictyn derivatives as anti-tumor agentsAbandonedOct 07, 04Feb 17, 05[A61K, C07C]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.